Evgenia Alimbarashvili

Evgenia Alimbarashvili

Auto-generated profile, based on publicly available information

Evgenia Alimbarashvili

Laboratory of Chromatin Biology, Institute of Cellular and Molecular Biology, Agricultural University of Georgia, 240 David Aghmashenebeli Alley, 0159, Tbilisi, Georgia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2024 in Heliyon
Verified
Journal Article
Open access
MKMargarita Karapetian
Margarita Karapetian
EAEvgenia Alimbarashvili
Evgenia Alimbarashvili
BVBoris Vishnepolsky
Boris Vishnepolsky
AGAndrei Gabrielian
Andrei Gabrielian
ARAlex Rosenthal
Alex Rosenthal
GZGiorgi Zaalishvili
Giorgi Zaalishvili
Antimicrobial peptides (AMPs) have emerged as promising candidates in combating antimicrobial resistance – a growing issue in healthcare. However, to develop AMPs into effective therapeutics, a thorough analysis and extensive investigations are essential. In this study, we employed an in silico approach to design cationic AMPs de novo, followed by their experimental testing. The antibacterial potential of de novo designed cationic AMPs, along with their synergistic properties in combination with conventional antibiotics was examined. Furthermore, the effects of bacterial inoculum density and metabolic state on the antibacterial activity of AMPs were evaluated. Finally, the impact of several potent AMPs on E. coli cell envelope and genomic DNA integrity was determined. Collectively, this comprehensive analysis provides insights into the unique characteristics of cationic AMPs.

31 October 2026 in Nucleic Acids Research
Verified
Journal Article
Open access
MPMalak Pirtskhalava
Malak Pirtskhalava
EAEvgenia Alimbarashvili
Evgenia Alimbarashvili
MGMaia Grigolava
Maia Grigolava
MCMindia Chubinidze
Mindia Chubinidze
BVBoris Vishnepolsky
Boris Vishnepolsky
AGAndrei Gabrielian
Andrei Gabrielian
The current peptide renaissance—driven by metagenomic and proteomic mining, molecular de-extinction, protein language models, and generative or evolutionary design—is producing millions of candidates, but useful machine learning depends on experimentally anchored, context-rich labels. The Database of Antimicrobial Activity and Structure of Peptides (DBAASP) is a manually curated resource linking peptides and peptidomimetics to quantitative antimicrobial, antibiofilm, anticancer, hemolytic, and mammalian-cell cytotoxicity measurements and their experimental conditions. DBAASP v4 contains >25 000 entries and extends the resource from a sequence-centered database to a structure-aware repository. Major additions include systematic SMILES representations, enhanced annotation of intrachain bonds and ring architectures, dedicated antibiofilm, and synergy records, PubChem links, >9200 molecular-dynamics trajectories, and new prediction services. The condition-resolved data support supervised learning, strain-, and target-specific models, model calibration, and surrogate fitness functions for genetic algorithms. SMILES representations further enable modeling of noncanonical peptides and peptidomimetics that cannot be adequately described by sequence alone. DBAASP therefore complements large peptide catalogues by providing the experimentally curated activity and structure layers, needed to convert sequence information into testable predictions, design, and optimization of biologically active compounds. DBAASP v4 is freely available at https://dbaasp.org.